| Active Ingredient | LEVETIRACETAM |
| Therapeutic Class | ANTICONVULSANTS MISCELLANEOUS |
| Indications | Epilepsy . |
| Caution | Somnolence, weakness, and dizziness, depression, nervousness. |
| Dose Range | Adult: Monotherapy: 500mg daily increased by 500mg increments every 2 weeks. Maximum dose 3g daily in divided doses. Adjunct therapy: 1g on first day of treatment, increased by 1g increments every 2-4 weeks. Maximum dose 3g daily in divided doses. Chil |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |